Also from this source

18 Jan, 2017, 09:00 ET Astellas to Acquire Ogeda SA


You just read:

Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions Due to Peanut Allergy

News provided by

Astellas Pharma Inc.

20 Dec, 2016, 08:00 ET